HRP20090147T3 - Pharmaceutical formulation comprising a pyrimidine-a-one derivative coated with an enteric polymer - Google Patents

Pharmaceutical formulation comprising a pyrimidine-a-one derivative coated with an enteric polymer

Info

Publication number
HRP20090147T3
HRP20090147T3 HR20090147T HRP20090147T HRP20090147T3 HR P20090147 T3 HRP20090147 T3 HR P20090147T3 HR 20090147 T HR20090147 T HR 20090147T HR P20090147 T HRP20090147 T HR P20090147T HR P20090147 T3 HRP20090147 T3 HR P20090147T3
Authority
HR
Croatia
Prior art keywords
enteric polymer
pyrimidine
pharmaceutical formulation
derivative coated
alkyl
Prior art date
Application number
HR20090147T
Other languages
English (en)
Croatian (hr)
Inventor
Marinus J. Van Schie Dirk
Original Assignee
Glaxo Group Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Limited filed Critical Glaxo Group Limited
Publication of HRP20090147T3 publication Critical patent/HRP20090147T3/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/284Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846Poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HR20090147T 2003-09-02 2009-03-13 Pharmaceutical formulation comprising a pyrimidine-a-one derivative coated with an enteric polymer HRP20090147T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0320522.6A GB0320522D0 (en) 2003-09-02 2003-09-02 Formulation
PCT/EP2004/009726 WO2005021002A1 (en) 2003-09-02 2004-08-31 Pharmaceutical formulation comprising a pyrimidine-a-one derivative coated with an enteric polymer

Publications (1)

Publication Number Publication Date
HRP20090147T3 true HRP20090147T3 (en) 2009-04-30

Family

ID=28686767

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20090147T HRP20090147T3 (en) 2003-09-02 2009-03-13 Pharmaceutical formulation comprising a pyrimidine-a-one derivative coated with an enteric polymer

Country Status (31)

Country Link
US (2) US20060287346A1 (es)
EP (1) EP1663243B1 (es)
JP (1) JP4892346B2 (es)
KR (1) KR101115984B1 (es)
CN (2) CN102204891B (es)
AR (1) AR045547A1 (es)
AT (1) ATE422889T1 (es)
AU (1) AU2004268376B2 (es)
BR (1) BRPI0414038A (es)
CA (1) CA2537178C (es)
CY (1) CY1108953T1 (es)
DE (1) DE602004019547D1 (es)
DK (1) DK1663243T3 (es)
ES (1) ES2319124T3 (es)
GB (1) GB0320522D0 (es)
HK (1) HK1091734A1 (es)
HR (1) HRP20090147T3 (es)
IL (1) IL173910A (es)
IS (1) IS2677B (es)
MA (1) MA28033A1 (es)
MX (1) MXPA06002436A (es)
MY (1) MY139165A (es)
NO (1) NO333744B1 (es)
NZ (1) NZ545453A (es)
PL (1) PL1663243T3 (es)
PT (1) PT1663243E (es)
RU (1) RU2359660C2 (es)
SI (1) SI1663243T1 (es)
TW (1) TWI343257B (es)
WO (1) WO2005021002A1 (es)
ZA (1) ZA200601599B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0320522D0 (en) * 2003-09-02 2003-10-01 Glaxo Group Ltd Formulation
MX2009012188A (es) 2007-05-11 2010-02-24 Univ Jefferson Métodos de tratamiento y prevención de enfermedades y desórdenes neurodegenerativos.
KR101563753B1 (ko) 2007-05-11 2015-10-27 더 트러스티스 오브 더 유니버시티 오브 펜실바니아 피부 궤양의 치료 방법
NZ595987A (en) 2009-04-24 2014-02-28 Iceutica Pty Ltd A novel formulation of diclofenac
EP2651403B1 (en) 2010-12-17 2020-12-02 Glaxo Group Limited Use of lp-pla2 inhibitors in the treatment and prevention of eye diseases
US9173884B2 (en) 2011-11-30 2015-11-03 Trustees Of Boston College Inhibitors of phosphodiesterase 11 (PDE11)
US9526734B2 (en) 2014-06-09 2016-12-27 Iceutica Pty Ltd. Formulation of meloxicam
EP3172211B1 (en) 2014-07-22 2019-07-03 GlaxoSmithKline Intellectual Property Development Limited Tricyclic imidazo-pyrimidinone derivatives for the treatment of diseases mediated by lp-pla2

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3619570C1 (en) 1986-06-11 1987-10-29 Kneipp Werke Kneipp Mittel Zen Coated garlic tablet
US4971805A (en) * 1987-12-23 1990-11-20 Teysan Pharmaceuticals Co., Ltd. Slow-releasing granules and long acting mixed granules comprising the same
IT1227899B (it) * 1988-12-23 1991-05-14 Poli Ind Chimica Spa Rivestimento totale o parziale di principi attivi farmaceutici e relative composizioni
TW209174B (es) * 1991-04-19 1993-07-11 Takeda Pharm Industry Co Ltd
JPH07223970A (ja) * 1994-02-10 1995-08-22 Tanabe Seiyaku Co Ltd 消化管内適所放出製剤
JP2917799B2 (ja) * 1994-03-11 1999-07-12 田辺製薬株式会社 消化管内適所放出型製剤
JP3185206B2 (ja) * 1995-07-20 2001-07-09 田辺製薬株式会社 消化管下部放出型被覆カプセル製剤
SG80553A1 (en) 1995-07-20 2001-05-22 Tanabe Seiyaku Co Pharmaceutical preparation in form of coated capsule releasable at lower part of digestive tract
CN1147291C (zh) * 1996-06-06 2004-04-28 拜福丹公司 用于口服制剂的含有藻酸的肠溶包衣
DE59702733D1 (de) 1996-08-15 2001-01-11 Losan Pharma Gmbh Gut schluckbare orale arzneiform
US6296876B1 (en) * 1997-10-06 2001-10-02 Isa Odidi Pharmaceutical formulations for acid labile substances
AU3731699A (en) * 1998-05-18 1999-12-06 Takeda Chemical Industries Ltd. Orally disintegrable tablets
CZ20011629A3 (cs) 1998-11-12 2001-12-12 Smithkline Beecham Plc Farmaceutický prostředek pro upravené uvolňování senzitizéru inzulínu a jiných antidiabetických přípravků
US6268385B1 (en) * 1999-08-26 2001-07-31 Robert R. Whittle Dry blend pharmaceutical formulations
ES2330552T3 (es) * 2000-02-16 2009-12-11 Smithkline Beecham Plc Derivados de pirimidin-5-ona como inhibidores de ldl-pla2.
AUPQ672800A0 (en) * 2000-04-06 2000-05-04 Natraherbal Pty Ltd Garlic supplement for deodoriser
CA2413330A1 (en) * 2000-06-28 2002-01-03 Smithkline Beecham P.L.C. Wet milling process
ATE508725T1 (de) 2001-06-20 2011-05-15 Takeda Pharmaceutical Verfahren zur herstellung von tabletten
JP5138856B2 (ja) * 2001-06-20 2013-02-06 武田薬品工業株式会社 錠剤の製造方法
RU2203671C1 (ru) 2002-03-25 2003-05-10 Общество С Ограниченной Ответственностью "Научно-Технологическая Фармацевтическая Фирма "Полисан" Противовирусный лекарственный препарат для перорального применения
GB0320522D0 (en) * 2003-09-02 2003-10-01 Glaxo Group Ltd Formulation

Also Published As

Publication number Publication date
RU2359660C2 (ru) 2009-06-27
BRPI0414038A (pt) 2006-10-24
GB0320522D0 (en) 2003-10-01
IL173910A (en) 2010-11-30
CN1874778B (zh) 2011-06-22
ZA200601599B (en) 2007-05-30
CY1108953T1 (el) 2014-07-02
EP1663243A1 (en) 2006-06-07
NZ545453A (en) 2009-12-24
US20060287346A1 (en) 2006-12-21
ES2319124T3 (es) 2009-05-04
NO333744B1 (no) 2013-09-09
CN102204891A (zh) 2011-10-05
JP2007504195A (ja) 2007-03-01
AR045547A1 (es) 2005-11-02
EP1663243B1 (en) 2009-02-18
PT1663243E (pt) 2009-04-27
CA2537178A1 (en) 2005-03-10
DE602004019547D1 (de) 2009-04-02
MY139165A (en) 2009-08-28
TW200517113A (en) 2005-06-01
CA2537178C (en) 2013-03-19
AU2004268376A1 (en) 2005-03-10
PL1663243T3 (pl) 2009-07-31
MA28033A1 (fr) 2006-07-03
KR101115984B1 (ko) 2012-03-13
US8772303B2 (en) 2014-07-08
TWI343257B (en) 2011-06-11
CN102204891B (zh) 2013-08-21
IS8366A (is) 2006-03-20
NO20061514L (no) 2006-04-03
JP4892346B2 (ja) 2012-03-07
SI1663243T1 (sl) 2009-06-30
MXPA06002436A (es) 2006-06-20
CN1874778A (zh) 2006-12-06
AU2004268376B2 (en) 2010-04-22
WO2005021002A1 (en) 2005-03-10
IS2677B (is) 2010-09-15
IL173910A0 (en) 2006-07-05
ATE422889T1 (de) 2009-03-15
HK1091734A1 (en) 2007-01-26
RU2006110546A (ru) 2006-08-10
DK1663243T3 (da) 2009-05-04
KR20060118422A (ko) 2006-11-23
US20090306113A1 (en) 2009-12-10

Similar Documents

Publication Publication Date Title
HRP20090147T3 (en) Pharmaceutical formulation comprising a pyrimidine-a-one derivative coated with an enteric polymer
RS50519B (sr) Supstituisani derivati 8'-piri(mi)dinil-dihidrospiro- /cikloalkilamin/-pirimido/1,2-a/pirimidin-6-ona
HUP0402313A2 (hu) Szerotonin újrafelvételt gátló fenilpiperazin-származékok, az ezeket tartalmazó gyógyászati készítmények és alkalmazásuk
PT1289955E (pt) Piperidinas para utilizacao como antagonistas dos receptores da orexina
WO2002089800A3 (en) N-aroyl cyclic amine derivatives as orexin receptor antagonists
HUP0400828A2 (hu) Kondenzált heterociklikus aminopirimidinek, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények
HRP20040429B1 (en) Sulphonamide derivatives, the preparation thereof and the application of same as medicaments
CO5280046A1 (es) Agonistas alfa 7 y sus composiciones farmaceuticas
HRP20050645A2 (en) Biphenyl derivatives and their use as fungicides
GB0128499D0 (en) Therapeutic agents
RS51795B (en) 2-AMINO-7,8-DIHYDRO-6H-PIRIDO [4,3-D] PYRIMIDINE-5-ONE, A PROCEDURE FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
DE60226875D1 (de) Orthosubstituierte arylamide zur bekämpfung von wirbellosen schädlingen
BG104248A (en) Benzamidoxim derivatives, intermediate products and methods for preparing and using them as fungicides
AR007077A1 (es) Derivados tetrahidroisoquinolina, un procedimiento para su preparacion, una composicion farmaceutica que los contiene, el uso de los mismos parala fabricacion de un medicamento
HUP0004333A2 (hu) Új triazolo [4,5-d] pirimidin-származékok, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények
RS51674B (en) PIPERIDIN-4-IL-PIRIDAZIN-3-ILAMINE DERIVATIVES AS A FAST DISSOCATING DOPAMIN 2 RECEIVER ANTAGONISTS
NO306237B1 (no) Anvendelse av xantinderivater som antidepressive midler
RS51136B (sr) Supstituisani pirolopiridini, kompozicije koje ih sadrže, postupak za njihovo dobijanje i upotreba
RS49921B (sr) Terapeutski biaril derivati
WO2008087611A3 (en) Pyrrolidine- and piperidine- bis-amide derivatives
HUP9901613A2 (hu) Szubsztituált tetraciklusos kondenzált furán-amin-származékok, eljárás előállításukra, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények
RS52518B (en) 4-ALCOXYPYRIDASINE DERIVATIVES AS A FAST DISSOCATING DOPAMINE 2 RECEPTOR ANTAGONISTS
HUP0201722A2 (hu) Gyógyászati készítmények alkoholizmus és alkoholfüggőség kezelésére
RU2010116779A (ru) Производное амида индазолакриловой кислоты
RS51126B (sr) Postupak za pripremanje mezilata piperazin derivata